ANI Pharmaceuticals files 8-K for investor presentation at conferences; no financial details provided

ANI PHARMACEUTICALS INC

CEO Nikhil Lalwani to present at H.C. Wainwright and Morgan Stanley healthcare conferences on Sep 8-9, 2025.
Updated investor presentation furnished as Exhibit 99.1 but content not available in extracted filing.
No specific financial results, guidance, or material operational updates disclosed in the filing body.
Filing under Items 2.02 and 7.01 is routine and does not contain new performance data.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.